Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

The Oncology Institute Inc (TOI)

The Oncology Institute Inc (TOI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

The Oncology Institute Inc 18000 STUDEBAKER ROAD SUITE 800 CERRITOS CA 90703 USA

https://theoncologyinstitute.com Employees: 641 P: 56-735-3226

Sector:

Medical

Description:

The Oncology Institute is involved in providing value-based oncology care. The Oncology Institute, formerly known as DFP Healthcare Acquisitions Corp., is based in NEW YORK.

Key Statistics

Overview:

Market Capitalization, $K 308,378
Enterprise Value, $K 352,208
Shares Outstanding, K 98,839
Float, K 90,438
% Float 91.50%
Short Interest, K 8,983
Short Float 9.09%
Days to Cover 3.87
Short Volume Ratio 0.54
% of Insider Shareholders 8.50%
% of Institutional Shareholders 36.86%

Financials:

Annual Sales, $ 502,730 K
Annual Net Income, $ -60,610 K
Last Quarter Sales, $ 141,960 K
Last Quarter Net Income, $ -7,510 K
EBIT, $ -29,150 K
EBITDA, $ -13,830 K

Growth:

1-Year Return 110.81%
3-Year Return 352.24%
5-Year Return -68.97%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.06 on 03/12/26
Next Earnings Date 05/13/26
Earnings Per Share ttm -0.53
EPS Growth vs. Prev Qtr 57.14%
EPS Growth vs. Prev Year 57.14%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

TOI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -33.70%
Profit Margin % -12.06%
Debt/Equity -4.92
Price/Sales 0.62
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.16
Interest Coverage -4.38
60-Month Beta 0.17
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.